Facebook
Twitter
LinkedIn
Forward
Mayo Clinic Update in Urology 2017
Course Directors: David Thiel, M.D., Gregory Broderick, M.D.
The diagnosis and management of many urologic conditions has been influenced by recent medical, surgical, and technological advances in the field. This course will make use of the world class Urologic surgical expertise present at the three Mayo Clinic sites in Rochester, MN; Scottsdale, AZ; and Jacksonville, FL to provide community and academic urologists with a comprehensive update on the field of clinical urology. The clinician will benefit from an update on novel therapies for various urologic conditions: prostate cancer, kidney cancer, bladder cancer, men’s sexual health, BPH and incontinence.
Registration Fees
On or before | After | |
Physicians and Scientists: | $900 | $950 |
Residents, Fellows, PA’s, Nurses, Allied Health and Retirees: | $600 | $650 |
Spouse/Guest *Includes continental breakfast for five days | $200.00 | $200.00 |
Child 6-18 years *Includes continental breakfast for five days | $100.00 | $100.00 |
| Child 5 years and under | Free | Free |
Additional Information
Credit Information
Lodging Accommodations
Program Agenda
Course Brochure
Target Audience
This course is designed for Physicians: General Urologists, Robotic Surgeons, Oncologists and Radiation Oncologists specializing throughout the spectrum of clinical urology.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Describe the current modalities for risk stratification of patients with newly-diagnosed prostate cancer.
- Discuss the proper use of image-guided focal prostate therapy for prostate cancer.
- Update on modern day prostatectomy: Robotic vs open surgery – Individualizing approaches to maximize urinary continence and erectile function and appropriate rehabilitation strategies for each.
- Update optimal approaches for high grade prostate cancer. Surgery vs. Radiation and timing of adjuvant/neo-adjuvant therapy.
- Evaluate recent advances in systemic therapy for advanced prostate carcinoma.
- Identify the roles of adjuvant and salvage therapies for patients with biochemical recurrence after radical prostatectomy.
- Recognize the various surgical and medical strategies for Peyronie’s disease, and determine the appropriate timing/selection of each in order to maximize treatment approach.
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Available Credit
- 18.75 AMA PRA Category 1 Credit™
- 18.75 AOA
- 18.75 Attendance